Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

This publication has 32 references indexed in Scilit:

• ABC of heart failure: Management: diuretics, ACE inhibitors, and nitrates
  BMJ, 2000
• Effects of losartan and captopril on QT dispersion in elderly patients with heart failure
  The Lancet, 1999
• Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design
  The American Journal of Cardiology, 1999
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
  The Lancet, 1999
• Experimental evidence to support ELITE
  The Lancet, 1998
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
  Published by Elsevier ,1997
• Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
  International Journal of Cardiology, 1997
• Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
  The American Journal of Cardiology, 1995
• Antiarrhythmic effects of ACE inhibitors: a matter of faith or reality?
  Cardiovascular Research, 1994
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987